Myeloma Archives - Oncology Nurse Advisor Thu, 07 Mar 2024 14:43:17 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png Myeloma Archives - Oncology Nurse Advisor 32 32 Postoperative Radiotherapy Following Spinal Surgery Safe, Effective in Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/multiple-myeloma-spinal-surgery-post-operative-radiotherapy-safe-effective/ Thu, 07 Mar 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=117164 The Role of Physician-AI Interaction in the Treatment of Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/multiple-myeloma-role-physician-ai-interaction-treatment-risk/ Tue, 05 Mar 2024 14:25:00 +0000 https://www.oncologynurseadvisor.com/?p=117083 Doctor on computer.Researchers sought to determine the potential role for physician-AI interactions in the treatment of patients with multiple myeloma.]]> Social Support Appears to Affect HRQoL Among Patients With Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/multiple-myeloma-social-support-health-quality-life-treatment-risk/ Mon, 04 Mar 2024 14:10:00 +0000 https://www.oncologynurseadvisor.com/?p=116906 Belantamab Mafodotin Regimen Bests Standard Care in Rel/Ref Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/belantamab-mafodotin-multiple-myeloma-standard-care/ Thu, 15 Feb 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=116599 VPEQ-CSPS Validated as Tool to Assess Patient Preferences for MM Treatment https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/multiple-myeloma-vpeq-csps-validated-tool-assess-patient-preferences-treatment/ Wed, 14 Feb 2024 14:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116693 Triplet Therapy Including Belamaf Prolongs Survival in Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/triplet-therapy-including-belamaf-prolongs-survival-in-multiple-myeloma/ Tue, 13 Feb 2024 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116653 Diabetes May Contribute to Disparities in Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/diabetes-contribute-disparities-multiple-myeloma/ Fri, 26 Jan 2024 15:20:00 +0000 https://www.oncologynurseadvisor.com/?p=116107 High BMI in Early Adulthood Increases Multiple Myeloma Risk Among Black Women https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/multiple-myeloma-high-bmmi-early-adulthood-black-women-treatment-risk/ Mon, 22 Jan 2024 16:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116148 Robust Score Can ID Infection Risk in Newly Diagnosed Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/robust-score-can-id-infection-risk-in-newly-diagnosed-multiple-myeloma/ Wed, 27 Dec 2023 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115051 Cropped shot of a focused middle aged doctor consoling with a patient inside of his office during the dayLow platelet count, ISS III, higher WHO performance status, age older than 60 years are risk factors for severe infection/death.]]> Linvoseltamab Shows Promising Results in Relapsed/Refractory Multiple Myeloma https://www.oncologynurseadvisor.com/home/cancer-types/multiple-myeloma/multiple-myeloma-linvoseltamab-promising-results-treatment-risk/ Fri, 13 Oct 2023 14:40:00 +0000 https://www.oncologynurseadvisor.com/?p=111331 MyelomaResearchers sought to determine whether linvoseltamab would improve responses in patients with relapsed/refractory multiple myeloma.]]>